Foghorn Therapeutics, Inc. (FHTX)
3.64
+0.01
(+0.28%)
USD |
NASDAQ |
Jun 03, 16:00
3.635
0.00 (0.00%)
After-Hours: 19:59
Foghorn Therapeutics Shareholders Equity (Quarterly) : -76.41M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.505B |
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
| Oncolytics Biotech, Inc. | -5.13M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Anixa Biosciences, Inc. | 15.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 222.17M |
| Total Liabilities (Quarterly) | 298.58M |
| Debt to Equity Ratio | -0.5496 |
| Current Ratio | 2.920 |
| Net Debt Paydown Yield | -0.35% |